NHL-35700

N/A

Report date: 2024/04/03 20:05:50
NME

Base Information

Drug NameNHL-35700
Drug Alias NameNHL35700NHL-35700
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor modulators
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A